LabEx Medalis

Transmembrane domain targeting peptide antagonizing ErbB2/Neu inhibits breast tumor growth and metastasis.

Alexia Arpel1,5, Paul Sawma2, Caroline Spenlé1, Justine Fritz1, Lionel Meyer1, Norbert Garnier3, Inés Velázquez-Quesada1#, Thomas Hussenet1#, Samia Aci-Sèche3,4, Nadège Baumlin1, Monique Genest3, David Brasse5, Pierre Hubert2, Gérard Crémel1, Gertraud Orend1, Patrice Laquerrière5 and Dominique Bagnard1*

1 INSERM U 1109, Labex Medalis, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg University, Strasbourg F-67200, France

2 CNRS LISM UMR 7255, Aix Marseille University, Marseille F-13402, France

3 CNRS UPR 4301, Center for Molecular Biophysics, Orleans University, Orleans F-45000, France

4 ICOA UMR 7311, Orleans University, Orleans F-45100, France

5 CNRS UMR 7178, Institut Pluridisciplinaire Hubert Curien, Strasbourg University, Strasbourg F-67037, France

Cell Rep. 2014 Sep 9. pii: S2211-1247(14)00628-7.

DOI

You are here: Publications Angiogenesis and tumoral invasion